参考文献/References:
[1]Das A,Stroud S,Mehta A,et al.New treatments for diabetic retinopathy[J].Diabetes Obesity&Metabolism,2015,17(3):219-230. [2]Cai S,Bressler NM.Aflibercept,bevacizumab or ranibizumab for diabetic macular oedema:Recent clinically relevant findings from DRCR.net Protocol T[J].Current Opinion in Ophthalmology,2017,28(6):1. [3]Heitzig N,Brinkmann BF,Koerdt SN,et al.Annexin A8 promotes VEGF-A driven endothelial cell sprouting[J].Cell Adhesion&Migration,2017,11(3):275-287. [4]Mohamed QA,Fletcher EC,Buckle M.Diabetic retinopathy:intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema[J].Bmj Clinical Evidence,2016(2016):0702. [5]苏龙. VEGI在糖尿病视网膜病变患者中的表达及对视网膜血管新生作用的研究[D].天津医科大学，2018. [6]吴丽萍,胡春玲,张悦,等2型糖尿病患者发生糖尿病视网膜病变的影响因素分析[J].中国医师杂志,2020,22(7):1049-1052. [7]Semeraro F,Cancarini A,dell’Omo R,et al.Diabetic Retinopathy:Vascular and Inflammatory Disease[J].Journal of Diabetes Research,2015(2015):582060. [8]Joon S,Joseph M.VEGF Signaling in Neurological Disorders[J].International Journal of Molecular Sciences,2018,19(1):275. [9]Juliana SP,Ferrao,Antenor P,et al.Vascular endothelial growth factor C treatment for mouse hind limb lymphatic revascularization[J].Veterinary Medicine and Science,2019,5(2):249-259. [10]Lv J,Zeng J,Guo F,et al.Endothelial Cdc42 deficiency impairs endothelial regeneration and vascular repair after inflammatory vascular injury[J].Respir Res,2018,19(1):27. [11]Al-Kharashiv AS.Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy[J].Saudi Journal of Ophthalmology,2018,32(4):318-323. [12]Kinoshita S, Noda K, Saito W,et al.Vitreous levels of vascular endothelial growth factor-B in proliferative diabetic retinopathy[J].Acta Ophthalmologica,2016,94(6):e521-e523. [13]Staels W,Heremans Y,Heimberg H,et al.VEGF-A and blood vessels:a beta cell perspective[J].Diabetologia,2019,62(11):1961-1968. [14]Moessinger C,Nilsson I,Muhl L,et al.VEGF-B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content[J].EMBO Reports,2020,21(7):e49343. [15]Heinolainen K,Karaman S,D’Amico G,et al.VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling[J].Circulation Research,2017,120(9):1414. [16]Kaidonis G,Burdon KP,Gillies MC,et al.Common Sequence Variation in the VEGFC Gene Is Associated with Diabetic Retinopathy and Diabetic Macular Edema[J].Ophthalmology,2015,122(9):1828-1836. [17]Joana M, JoO CDS,Sara VP,et al.VEGF-B Levels in the Vitreous of Diabetic and Non-Diabetic Patients with Ocular Diseases and Its Correlation with Structural Parameters[J].Medical Sciences,2017,5(3):17. [18]Li Y,Chen D,Sun L,et al.Induced Expression of VEGFC,ANGPT,and EFNB2 and Their Receptors Characterizes Neovascularization in Proliferative Diabetic Retinopathy[J].Investigative Ophthalmology&Visual Science,2019,60(13):4084-4096. [19]Muhl L,Moessinger C,Adzemovic MZ,et al.Expression of vascular endothelial growth factor(VEGF)-B and its receptor(VEGFR1)in murine heart,lung and kidney[J].Cell&Tissue Research,2016,365(1):51-63. [20]Vivien CJ,Pichol-Thievend C,Sim CB,et al.Vegfc/d-dependent regulation of the lymphatic vasculature during cardiac regeneration is influenced by injury context[J].NPJ Regen Med,2019,4(1):1-14. [21]Bui HM,Enis D,Robciuc MR,et al.Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD[J].Journal of Clinical Investigation,2016,126(6):2167. [22]Takeda Y,Matoba K,Kawanami D,et al.1692-P:Ablation of Endothelial ROCK2 Promotes Fat Browning and Improves Metabolic Dysfunction[J].Diabetes,2020,69(Supplement 1):1692-P. [23]Huang D,Zhao C,Ju R,et al.VEGF-B inhibits hyperglycemia-and Macugen-induced retinal apoptosis[J].Rep,2016(6):26059. [24]Chakraborty A,Barajas S,Lammoglia GM,et al.Vascular Endothelial Growth Factor-D(VEGF-D)Overexpression and Lymphatic Expansion in Murine Adipose Tissue Improves Metabolism in Obesity[J].The American Journal of Pathology,2019,189(4):924-939. [25]Schlüter A,Aksan B,Diem R,,et al.VEGFD Protects Retinal Ganglion Cells and,consequently,Capillaries against Excitotoxic Injury[J].Molecular Therapy-Methods&Clinical Development,2019(17):281-299. [26]Khadim MT,Ahmed SA,Khan FA,et al.Evaluation of vascular endothelial growth factors A,C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder[J].Journal of the Pakistan Medical Association,2015,65(8):851-856. [27]Steven S,Marc A.Emerging Roles for VEGF-D in Human Disease[J].Biomolecules,2018,8(1):1. [28]Chen R,Lee C,Lin X,et al.Novel function of VEGF-B as an antioxidant and therapeutic implications[J].Pharmacological Research,2019(143):33-39. [29]Apte RS,Chen DS,Ferrara N.VEGF in Signaling and Disease: Beyond Discovery and Development[J].Cell,2019,176(6):1248-1264. [30]Melincovici CS,Boca AB,Uman S,et al.Vascular endothelial growth factor(VEGF)-key factor in normal and pathological angiogenesis[J].Rom J Morphol Embryol,2018,59(2):455-467.
相似文献/References:
[1]郭 明,郑继伟,马丽平.25(OH)D3与糖尿病视网膜病变的关系研究[J].医学信息,2018,31(08):99.[doi:10.3969/j.issn.1006-1959.2018.08.031]
GUO Ming,ZHENG Ji-wei,MA Li-ping.Study on the Relationship between 25(OH)D3 and Diabetic Retinopathy[J].Medical Information,2018,31(05):99.[doi:10.3969/j.issn.1006-1959.2018.08.031]
[2]闫宇梅.血清胱抑素C及同型半胱氨酸与2型糖尿病
视网膜病变的相关性分析[J].医学信息,2018,31(17):89.[doi:10.3969/j.issn.1006-1959.2018.17.027]
YAN Yu-mei.Correlation between Serum Cystatin C and Homocysteine and Type 2 Diabetic Retinopathy[J].Medical Information,2018,31(05):89.[doi:10.3969/j.issn.1006-1959.2018.17.027]
[3]罗妮娜,金昌德,陈文莉.中西医结合护理在老年糖尿病视网膜病变低视力患者中应用及效果观察[J].医学信息,2018,31(19):165.[doi:10.3969/j.issn.1006-1959.2018.19.052]
LUO Ni-na,JIN Chang-de,CHEN Wen-li.Application and Effect of Integrated Traditional Chinese and Western Medicine Nursing in Elderly Patients with Diabetic Retinopathy with Low Visual[J].Medical Information,2018,31(05):165.[doi:10.3969/j.issn.1006-1959.2018.19.052]
[4]宋晨音.他汀类药物在糖尿病治疗中的研究[J].医学信息,2022,35(17):166.[doi:10.3969/j.issn.1006-1959.2022.17.045]
SONG Chen-yin.Study of Statins in the Treatment of Diabetes Mellitus[J].Medical Information,2022,35(05):166.[doi:10.3969/j.issn.1006-1959.2022.17.045]
[5]苟青青,李 鸿.糖尿病相关眼部改变及并发症的研究[J].医学信息,2022,35(18):153.[doi:10.3969/j.issn.1006-1959.2022.18.043]
GOU Qing-qing,LI Hong.Study on Diabetes-related Ocular Changes and Complications[J].Medical Information,2022,35(05):153.[doi:10.3969/j.issn.1006-1959.2022.18.043]
[6]马 斌,王彩星,王金虹.基于文献计量学的我国2型糖尿病护理研究现状及热点分析[J].医学信息,2021,34(22):12.[doi:10.3969/j.issn.1006-1959.2021.22.004]
MA Bin,WANG Cai-xing,WANG Jin-hong.Analysis of Current Status and Hot Spots in Nursing Research of Type 2 Diabetes Mellitus in China Based on Bibliometrics[J].Medical Information,2021,34(05):12.[doi:10.3969/j.issn.1006-1959.2021.22.004]
[7]潘 浩.依帕司他片辅助治疗对糖尿病视网膜病变患者SOD、TAOC及TNF-α水平的影响[J].医学信息,2020,33(05):100.[doi:10.3969/j.issn.1006-1959.2020.05.030]
PAN Hao.Effects of Adjuvant Epalrestat on SOD,TAOC and TNF-α Levels in Patients with Diabetic Retinopathy[J].Medical Information,2020,33(05):100.[doi:10.3969/j.issn.1006-1959.2020.05.030]
[8]孙天慧,谭晓霞,连晓芬,等.2型糖尿病合并视网膜病变的影响因素分析[J].医学信息,2020,33(21):94.[doi:10.3969/j.issn.1006-1959.2020.21.027]
SUN Tian-hui,TAN Xiao-xia,LIAN Xiao-fen,et al.Analysis of Influencing Factors of Type 2 Diabetes with Retinopathy[J].Medical Information,2020,33(05):94.[doi:10.3969/j.issn.1006-1959.2020.21.027]
[9]李 娟,冯双双,康京京,等.尿β2微球蛋白水平与2型糖尿病患者视网膜病变和肾脏病变的相关性[J].医学信息,2020,33(19):99.[doi:10.3969/j.issn.1006-1959.2020.19.029]
LI Juan,FENG Shuang-shuang,KANG Jing-jing,et al.Correlation Between Urine β2 Microglobulin Level and Retinopathy and Nephropathy in Type 2 Diabetic Patients[J].Medical Information,2020,33(05):99.[doi:10.3969/j.issn.1006-1959.2020.19.029]
[10]杨文彦.雷珠单抗玻璃体腔注射联合激光治疗对糖尿病视网膜病变患者视力水平的影响[J].医学信息,2023,36(11):110.[doi:10.3969/j.issn.1006-1959.2023.11.021]
YANG Wen-yan.Effect of Intravitreal Injection of Ranibizumab Combined with Laser Therapy on Visual Acuity in Patients with Diabetic Retinopathy[J].Medical Information,2023,36(05):110.[doi:10.3969/j.issn.1006-1959.2023.11.021]